Immunoglobulins G of Patients with Schizophrenia Protects from Superoxide: Pilot Results

This study aimed to evaluate the superoxide dismutase (SOD) activity of IgG in patients with schizophrenia. After signing informed consent, we included 67 patients with schizophrenia (34 people with acute schizophrenia and 33 individuals were on outpatient treatment in therapeutic remission) and 14...

Descripción completa

Detalles Bibliográficos
Autores principales: Mednova, Irina A., Smirnova, Liudmila P., Vasilieva, Alisa R., Kazantseva, Daria V., Epimakhova, Elena V., Krotenko, Nina M., Semke, Arkadiy V., Ivanova, Svetlana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503855/
https://www.ncbi.nlm.nih.gov/pubmed/36143234
http://dx.doi.org/10.3390/jpm12091449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503855/
https://www.ncbi.nlm.nih.gov/pubmed/36143234
http://dx.doi.org/10.3390/jpm12091449

Ejemplares similares